Legend Biotech Corp Adr (LEGN)

Jun 15, 2026

Legend Biotech reports early trial success for in vivo CAR-T therapy - Investing.com

Jun 15, 2026

Jun 14, 2026

Legend Biotech Establishes Clinical Proof-of-Concept for LB2501, a Potential First-in-Class In Vivo CD19/CD20 Dual-Targeting CAR-T, in Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma - GlobeNewswire Inc.

Jun 14, 2026

Jun 03, 2026

UBS raises Legend Biotech stock price target on NHL therapy outlook - Investing.com

Jun 03, 2026

Jun 02, 2026

GENSCRIPT BIO Spikes 19% as Legend Biotech Corporation (LEGN.US) Announces Positive Prelim Clinical Data for Lymphoma Therapy - AASTOCKS.com

Jun 02, 2026

Jun 02, 2026

Cancer Drug Proves 100% Successful In Early Study; What's Next? - Investor's Business Daily

Jun 02, 2026

Jun 02, 2026

Keep an eye on the top gainers and losers in Tuesday's session. - ChartMill

Jun 02, 2026

Jun 02, 2026

Legend Biotech reports phase 1 data for in vivo CAR-T therapy - Investing.com

Jun 02, 2026

Jun 02, 2026

金斯瑞生物科技(01548.HK)升19% 傳奇生物(LEGN.US)宣布治療淋巴瘤藥物初步臨床數據現積極信號 - AASTOCKS.com

Jun 02, 2026

Jun 01, 2026

RBC Capital reiterates Legend Biotech stock rating at Outperform By Investing.com - Investing.com South Africa

Jun 01, 2026

Jun 01, 2026

RBC Capital reiterates Legend Biotech stock rating at Outperform - Investing.com

Jun 01, 2026

Jun 01, 2026

H.C. Wainwright reiterates Legend Biotech stock rating at buy - Investing.com

Jun 01, 2026

May 31, 2026

Legend Biotech Conference Spotlights CARVYKTI’s Curative Potential, Earlier Use - Yahoo Finance

May 31, 2026

May 27, 2026

H.C. Wainwright reiterates Legend Biotech stock rating at buy By Investing.com - Investing.com South Africa

May 27, 2026

May 21, 2026

GENSCRIPT BIO (01548.HK): Legend Biotech Corporation (LEGN.US) Presents Multiple Research Findings at ASCO Annual Meeting in the US - AASTOCKS.com

May 21, 2026

May 18, 2026

Earnings call transcript: Legend Biotech reports Q1 2026 loss, stock surges 12% - Investing.com

May 18, 2026

May 17, 2026

A China Tech Fund Opens a Biotech Position — Here's What That Actually Signals - AOL.com

May 17, 2026

May 13, 2026

Legend Biotech stock price target raised to $64 by RBC Capital - Investing.com South Africa

May 13, 2026

May 12, 2026

Legend Biotech Q1 2026 slides: strong sales growth, profitability delayed - Investing.com

May 12, 2026

May 12, 2026

Earnings call transcript: Legend Biotech’s Q1 2026 earnings miss forecasts By Investing.com - Investing.com South Africa

May 12, 2026

May 12, 2026

Earnings call transcript: Legend Biotech’s Q1 2026 earnings miss forecasts - Investing.com

May 12, 2026

May 12, 2026

Legend Biotech Q1 Earnings Call Highlights - Yahoo Finance

May 12, 2026

May 12, 2026

Legend Biotech (NASDAQ:LEGN) Q1 2026 Revenue Surges on CARVYKTI Growth, but EPS Falls Short - ChartMill

May 12, 2026

May 12, 2026

Legend Biotech stock rises 3% on strong Carvykti sales growth, despite missing estimates By Investing.com - Investing.com South Africa

May 12, 2026

May 12, 2026

Legend Biotech stock rises 3% on strong Carvykti sales growth, despite missing estimates - Investing.com

May 12, 2026

May 05, 2026

Zurcher Kantonalbank Zurich Cantonalbank Decreases Stake in Legend Biotech Corporation Sponsored ADR $LEGN - MarketBeat

May 05, 2026

May 04, 2026

Legend Biotech (NASDAQ:LEGN) Stock Price Up 7.7%Time to Buy? - MarketBeat

May 04, 2026

Apr 29, 2026

Legend Biotech Corporation Sponsored ADR (NASDAQ:LEGN) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat

Apr 29, 2026

Apr 28, 2026

Investors get Legend Biotech's first-quarter 2026 update on May 12 - Stock Titan

Apr 28, 2026

Apr 26, 2026

Legend Biotech (LEGN) moves 18.4% higher: Will this strength last? - MSN

Apr 26, 2026

Apr 25, 2026

Legend Biotech Corporation Sponsored ADR $LEGN Stock Holdings Lowered by Matthews International Capital Management LLC - MarketBeat

Apr 25, 2026

Apr 21, 2026

Legend Biotech (LEGN) Moves 18.4% Higher: Will This Strength Last? - Yahoo Finance

Apr 21, 2026

Apr 21, 2026

H.C. Wainwright reiterates Legend Biotech stock rating on M&A activity By Investing.com - Investing.com South Africa

Apr 21, 2026

Apr 21, 2026

Raymond James reiterates Legend Biotech stock rating on strong trial data - Investing.com

Apr 21, 2026

Apr 21, 2026

H.C. Wainwright reiterates Legend Biotech stock rating on M&A activity - Investing.com

Apr 21, 2026

Apr 21, 2026

Why Legend Biotech Stock Crushed the Market on Monday - AOL.com

Apr 21, 2026

Apr 20, 2026

RBC Capital reiterates Legend Biotech stock rating on pharma interest By Investing.com - Investing.com India

Apr 20, 2026

Apr 20, 2026

Nektar Therapeutics, Compass Pathways, Sila Realty Trust And Other Big Stocks Moving Higher On Monday - Benzinga

Apr 20, 2026

Apr 20, 2026

H.C. Wainwright reiterates Legend Biotech stock rating on pipeline progress - Investing.com

Apr 20, 2026

Apr 20, 2026

H.C. Wainwright reiterates Legend Biotech stock rating on pipeline progress By Investing.com - Investing.com India

Apr 20, 2026

Apr 17, 2026

HC Wainwright Boosts Earnings Estimates for Legend Biotech - MarketBeat

Apr 17, 2026

Apr 16, 2026

Legend Biotech (NASDAQ:LEGN) Trading 6.3% HigherStill a Buy? - MarketBeat

Apr 16, 2026

Apr 16, 2026

Q2 EPS Estimates for Legend Biotech Lowered by HC Wainwright - MarketBeat

Apr 16, 2026

Apr 15, 2026

H.C. Wainwright reiterates Legend Biotech stock rating on strong Carvykti sales - Investing.com

Apr 15, 2026

Apr 15, 2026

H.C. Wainwright reiterates Legend Biotech stock rating on strong Carvykti sales By Investing.com - Investing.com South Africa

Apr 15, 2026

Apr 04, 2026

Legend Biotech Corporation Sponsored ADR (NASDAQ:LEGN) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat

Apr 04, 2026

Apr 02, 2026

Top GainersStock ScreenerSnapshot - Finviz

Apr 02, 2026